ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01302847
Recruitment Status : Recruiting
First Posted : February 24, 2011
Last Update Posted : April 17, 2018
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)